A Randomised Trial of Imatinib Alternating With Regorafenib Compared to Imatinib Alone for the First Line Treatment of Advanced Gastrointestinal Stromal Tumour (GIST) (ALT GIST)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02365441 |
|
Recruitment Status : Unknown
Verified September 2016 by Australasian Gastro-Intestinal Trials Group.
Recruitment status was: Recruiting
First Posted : February 19, 2015
Last Update Posted : October 3, 2016
|
Sponsor:
Australasian Gastro-Intestinal Trials Group
Collaborators:
European Organisation for Research and Treatment of Cancer - EORTC
Scandinavian Sarcoma Group
Information provided by (Responsible Party):
Australasian Gastro-Intestinal Trials Group
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Unknown |
|---|---|
| Estimated Primary Completion Date : | December 2019 |
| Estimated Study Completion Date : | December 2020 |